Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/50000| Title: | Optimising drug therapy in older persons : design and implementation of a medication assessment tool for secondary prevention of stroke |
| Authors: | Gauci, Marise Wirth, Francesca Azzopardi, Lilian M. Serracino-Inglott, Anthony |
| Keywords: | Cerebrovascular disease -- Prevention Cerebrovascular disease -- Patients -- Malta -- Case studies Cerebrovascular disease -- Chemotherapy Older people -- Medical care -- Evaluation Geriatric pharmacology |
| Issue Date: | 2017-03 |
| Publisher: | University of Malta. Department of Pharmacy |
| Citation: | Gauci, M., Wirth, F., Azzopardi, L. M., & Serracino-Inglott, A. (2017, March). Optimising drug therapy in older persons: design and implementation of a medication assessment tool for secondary prevention of stroke. Poster session presented at the 22nd Congress of the European Association of Hospital Pharmacists, Cannes, France. |
| Abstract: | A poster presentation about optimising drug therapy in older persons: design and implementation of a medication assessment tool for secondary prevention of stroke. Introduction: Several characteristics of ageing make selection of appropriate drug therapy a challenging task. Optimisation of drug therapy in older persons may be facilitated by application of medication assessment tools. Objectives: To design, psychometrically evaluate and implement a medication assessment tool for secondary prevention of stroke (MAT-CVA) with particular relevance to older persons to assess adherence to clinical practice guidelines. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/50000 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Optimising_drug_therapy_in_older_persons_design_and_implementation_of_a_medication_assessment_2017.pdf | 993.98 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.